AI Weekly Malaysia

Summaries

Short AI and tech summaries with source links, signal scores, and why each update matters for builders, founders, and Malaysian tech workers.

Reset

Showing 1-2 of 2 results

DateProviderScoreSummary
17 Nov 2026, 10:50 PMTechCrunch3.0 Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Isomorphic Labs raised a $5B Series C co-led by Greenoaks and Sequoia, with Andreessen Horowitz joining and existing investors including Alphabet’s GV and CapitalG, Thrive, MGX, Temasek, and the UK Sovereign AI Fund. The DeepMind spinout says its AI drug-design engine has produced positive preclinical results in oncology and immunology, and it has deals with Eli Lilly, Novartis, and Johnson & Johnson; the round follows a $2.1B Series B in May and will fund the engine plus expansion into more medicine types. Isomorphic did not disclose a valuation, though Bloomberg reported it was seeking a $50B valuation; Demis Hassabis left the DeepMind CEO role to focus on drug discovery and became DeepMind chairman, after sharing the Nobel Prize in chemistry with John Jumper for AlphaFold.

Why: For most developers and SaaS founders, this is a biotech funding story with no direct tooling, API, or platform change to adopt; the concrete signal is that AlphaFold-derived commercial work is being capitalized at biotech scale ($5B round, reported $50B valuation target) and validated through pharma partnerships and preclinical results, not through a developer product. AI/ML learners should treat it as a long-horizon research-commercialization data point, not a reason to pivot into drug discovery, and local SaaS founders should not read it as a shift in Malaysian startup conditions.

17 Nov 2026, 10:00 PMTechCrunch2.0 Upside Foods can now make a million pounds of chicken a year without killing any animals

Upside Foods says it can now produce over one million pounds of cultivated chicken per year, following a 10,000-fold scale-up at its facility, and has secured additional FDA and USDA approvals. The chicken is now on menus at several California restaurants. For comparison, the first lab-grown burger in 2013 cost $300,000 to make; CEO Dr. Uma Valeti claims Upside can now match the price range of "really high quality organic chicken." MrBeast filmed a taste test in which he could not tell Upside's chicken from conventionally slaughtered chicken.

Why: There is no actionable takeaway here for developers, AI/ML learners, or SaaS founders — this is a biotech manufacturing milestone and consumer-food launch confined to California restaurants, with no API, pricing table, or tooling change. The only builder-relevant detail is the cost curve: $300,000 per burger in 2013 to claimed organic-chicken parity, which is a useful datapoint if you are modelling how far a capital-intensive process needs to fall before it becomes a real market — but nothing in this text tells a Malaysian software builder to change anything.

Top